BSACI position statement: Cost of living, health inequalities and the adverse additional impact on children and young people living with allergic conditions VIEW HERE
BSACI statement: NICE approval of Palforzia, a treatment for peanut allergy in children and young people VIEW HERE
Announcement UK Launches First National Allergy Strategy to Address Crisis Affecting Millions Read more
17 Sep 2026 Announcements, Latest news, Updated Spare Adrenaline in Schools Website Supports Implementation of New Allergy...
